In a series of 119 colorectal cancer tissues and their adjacent normal counterparts, immunohistochemical analysis of EZH2 showed that 69.7% of cases overexpressed EZH2, and overexpression was associated with advanced TNM stage and increased depth of invasion [11]. Here, EZH2 is linked to colorectal cancer.